Spasticity
- PMID: 19364449
- DOI: 10.1007/s11940-009-0018-4
Spasticity
Abstract
Treatment of spasticity requires a team approach, including the patient and caregivers, therapists, physicians, and surgeons. The team needs to determine what component of the spasticity interferes with function. Traditional therapy continues to dominate the therapy provided to patients who are living with spasticity. Treatment of increased tone must be part of the overall treatment plan for the patient. The plan may also include physical and occupational therapy, oral medication, injections of botulinum toxin, use of an intrathecal baclofen pump, or surgery. For patients with limited improvement from therapy, injections of botulinum toxin are often first-line treatment for focal spasticity involving overactive muscle groups. Botulinum toxin is safe when used at recommended doses and has limited side effects. The benefits of oral medications in patients with focal spasticity may be limited by adverse effects at higher doses. Refractory spasticity may be treated with intrathecal baclofen. Surgery is reserved for patients in whom the other modalities fail to provide meaningful improvement. Continued communication from all members of the team can assure the best spasticity management plan for the individual patient, but patients need to have realistic expectations about outcome.
Similar articles
-
Pharmacologic treatment of spasticity in children.Semin Pediatr Neurol. 2010 Dec;17(4):261-7. doi: 10.1016/j.spen.2010.10.009. Semin Pediatr Neurol. 2010. PMID: 21183133 Review.
-
Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity.Mult Scler Relat Disord. 2021 May;50:102831. doi: 10.1016/j.msard.2021.102831. Epub 2021 Feb 10. Mult Scler Relat Disord. 2021. PMID: 33618123
-
Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.J Rehabil Med. 2010 Oct;42(9):891-4. doi: 10.2340/16501977-0596. J Rehabil Med. 2010. PMID: 20878052
-
Botulinum toxin treatment of adult spasticity.Expert Rev Neurother. 2003 Nov;3(6):773-85. doi: 10.1586/14737175.3.6.773. Expert Rev Neurother. 2003. PMID: 19810880
-
Pharmacotherapy of spasticity in children with cerebral palsy.J Formos Med Assoc. 2011 Apr;110(4):215-22. doi: 10.1016/S0929-6646(11)60033-8. J Formos Med Assoc. 2011. PMID: 21540003 Review.
Cited by
-
Examining the role of intrinsic and reflexive contributions to ankle joint hyper-resistance treated with botulinum toxin-A.J Neuroeng Rehabil. 2023 Feb 7;20(1):19. doi: 10.1186/s12984-023-01141-8. J Neuroeng Rehabil. 2023. PMID: 36750869 Free PMC article.
-
Ultrasound-guided ethyl alcohol injection to the deep branch of the ulnar nerve to relieve hand spasticity in stroke patients: A case series.Transl Neurosci. 2021 Oct 1;12(1):346-350. doi: 10.1515/tnsci-2020-0188. eCollection 2021 Jan 1. Transl Neurosci. 2021. PMID: 34703625 Free PMC article.
-
A Review of Spasticity Treatments: Pharmacological and Interventional Approaches.Crit Rev Phys Rehabil Med. 2013;25(1-2):11-22. doi: 10.1615/CritRevPhysRehabilMed.2013007945. Crit Rev Phys Rehabil Med. 2013. PMID: 25750484 Free PMC article.
-
Effectiveness of Extracorporeal Shock Wave Therapy in Treatment of Spasticity of Different Aetiologies: A Systematic Review and Meta-Analysis.J Clin Med. 2024 Feb 26;13(5):1323. doi: 10.3390/jcm13051323. J Clin Med. 2024. PMID: 38592705 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources